Anavex Life Sciences Corp.AVXLNASDAQ

Revenue (LTM)

Net Income (LTM)

$-46M

-7.8% YoY

Free Cash Flow

$-39M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-42	-51↓21.4%	-56↓9.4%	-53↑5.2%	-51↑2.8%
Net Income	-38	-48↓26.6%	-48↑1.0%	-43↑9.5%	-46↓7.8%
EBITDA	-38	-48↓26.5%	-47↑2.3%	-43↑7.6%	-46↓7.8%
EPS Diluted	-0.54	-0.62↓14.8%	-0.60↑3.2%	-0.52↑13.3%	-0.54↓3.8%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	152	149↓1.9%	151↑1.3%	132↓12.5%	103↓22.4%
Total Current Assets	162	153↓5.5%	154↑1.1%	136↓12.2%	104↓23.4%
Total Assets	162	153↓5.5%	154↑1.1%	136↓12.2%	104↓23.4%
Total Current Liabilities	11	10↓5.4%	13↑22.7%	15↑22.1%	9↓41.5%
Total Liabilities	11	10↓5.4%	13↑22.7%	15↑22.1%	9↓41.5%
Total Equity	151	142↓5.5%	142↓0.4%	120↓15.2%	95↓21.1%
Total Debt	0	0	0	0	0
Net Debt	-152	-149↑1.9%	-151↓1.3%	-132↑12.5%	-103↑22.4%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-30	-24↑20.2%	-28↓14.6%	-31↓10.9%	-39↓26.7%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-30	-24↑20.2%	-28↓14.6%	-31↓10.9%	-39↓26.7%
Stock-Based Comp	8	18↑123.3%	16↓10.9%	9↓42.3%	12↑22.4%
Net Change in Cash	123	-3↓102.4%	2↑163.3%	-19↓1109.5%	-30↓57.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance